US hands Pfizer, BioNTech $1.95b order for 100m Covid vaccines
New York: The US government has agreed to pay $1.95 billion for 100 million doses of a potential Covid-19 vaccine...
New York: The US government has agreed to pay $1.95 billion for 100 million doses of a potential Covid-19 vaccine...
Washington: Researchers have created a virus in the lab that infects cells and interacts with antibodies just like the Covid-19...
New Delhi: The Serum Institute of India (SII) will soon apply to the Indian regulator for the licensure trials of...
London: The Covid-19 vaccine developed by scientists at the Oxford University produces strong immune responses in both parts of the...
Hyderabad: As part of human trials of Covaxin, India's first indigenous Covid-19 vaccine, two volunteers were given its first dose...
New Delhi: In a major development, AIIMS Delhi will begin human trials of India's first indigenous Covid-19 vaccine, Covaxin, from next...
Hyderabad: Hyderabad-based Bharat Biotech on Friday announced that the Phase-I clinical trials of India's first indigenous Covid-19 vaccine Covaxin began...
London: A Covid-19 vaccine developed by researchers at Oxford University generated an immune response against the disease in Phase-1 trial,...
Moscow: Russia has become the first nation to complete clinical trials of Covid-19 vaccine on humans, and the results have...
New Delhi: As soon as the Parliamentary standing committees started to resume work after a long spell of hibernation, it...